GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Plans » NeueHealth Inc (NYSE:NEUE) » Definitions » EV-to-Revenue

NEUE (NeueHealth) EV-to-Revenue : 1.20 (As of Jun. 25, 2025)


View and export this data going back to 2021. Start your Free Trial

What is NeueHealth EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, NeueHealth's enterprise value is $1,092.6 Mil. NeueHealth's Revenue for the trailing twelve months (TTM) ended in Mar. 2025 was $907.3 Mil. Therefore, NeueHealth's EV-to-Revenue for today is 1.20.

The historical rank and industry rank for NeueHealth's EV-to-Revenue or its related term are showing as below:

NEUE' s EV-to-Revenue Range Over the Past 10 Years
Min: -2.38   Med: 1.1   Max: 8.16
Current: 1.2

During the past 7 years, the highest EV-to-Revenue of NeueHealth was 8.16. The lowest was -2.38. And the median was 1.10.

NEUE's EV-to-Revenue is ranked worse than
70% of 20 companies
in the Healthcare Plans industry
Industry Median: 0.765 vs NEUE: 1.20

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2025-06-25), NeueHealth's stock price is $6.8396. NeueHealth's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2025 was $108.75. Therefore, NeueHealth's PS Ratio for today is 0.06.


NeueHealth EV-to-Revenue Historical Data

The historical data trend for NeueHealth's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NeueHealth EV-to-Revenue Chart

NeueHealth Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EV-to-Revenue
Get a 7-Day Free Trial - 1.33 2.18 1.16 1.22

NeueHealth Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.93 1.01 1.09 1.22 1.20

Competitive Comparison of NeueHealth's EV-to-Revenue

For the Healthcare Plans subindustry, NeueHealth's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


NeueHealth's EV-to-Revenue Distribution in the Healthcare Plans Industry

For the Healthcare Plans industry and Healthcare sector, NeueHealth's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where NeueHealth's EV-to-Revenue falls into.


;
;

NeueHealth EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

NeueHealth's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=1092.636/907.349
=1.20

NeueHealth's current Enterprise Value is $1,092.6 Mil.
NeueHealth's Revenue for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $907.3 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


NeueHealth  (NYSE:NEUE) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

NeueHealth's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=6.8396/108.753
=0.06

NeueHealth's share price for today is $6.8396.
NeueHealth's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $108.75.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


NeueHealth EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of NeueHealth's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


NeueHealth Business Description

Traded in Other Exchanges
N/A
Address
9250 NW 36th Street, Suite 420, Doral, FL, USA, 33178
NeueHealth Inc is a value-driven healthcare company grounded in the belief that all health consumers are entitled to high-quality, coordinated healthcare. It consists of two reportable segments: NeueCare - it's a value-driven care delivery business that manages risk in partnership with external payors and serves all populations across The Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act. NeueSolutions - it's a provider enablement business that includes a suite of technology, services, and clinical care solutions that empower providers to thrive in performance-based arrangements.
Executives
Jay Matushak officer: Chief Financial Officer C/O BRIGHT HEALTH GROUP, INC., 8000 NORMAN CENTER DRIVE, SUITE 900, MINNEAPOLIS MN 55437
Jeffrey J Scherman officer: Chief Accounting Officer C/O BRIGHT HEALTH GROUP, INC., 8000 NORMAN CENTER DRIVE, SUITE 1200, MINNEAPOLIS MN 55437
Mikan George Lawrence Iii director, officer: CEO and President 200 SW 1ST AVE, SUITE 1600, FORT LAUDERDALE FL 33301
Jeff Michael Craig officer: GC & CORPORATE SECRETARY C/O BRIGHT HEALTH GROUP INC, 8000 NORMAN CENTER DRIVE SUITE 1200, MINNEAPOLIS MN 55437
Jeffrey S Cook officer: CEO, NeueHealth C/O BRIGHT HEALTH GROUP INC, 8000 NORMAN CENTER DRIVE SUITE 1200, MINNEAPOLIS MN 55437
Cathy R Smith officer: CFO & CAO TARGET CORPORATION, 1000 NICOLLET MALL, TPS-3155, MINNEAPOLIS MN 55403
Manuel Kadre director 2020 SALZEDO STREET, SUITE 301, CORAL GABLES FL 33134
Jeffrey R Immelt director GENERAL ELECTRIC COMPANY, 41 FARNSWORTH STREET, BOSTON MA 02210
Nea 18 Vge Gp, Llc 10 percent owner C/O NEW ENTERPRISE ASSOCIATES, 1954 GREENSPRING DRIVE, SUITE 600, TIMONIUM MD 21093
Nea Partners 18 Vge, L.p. 10 percent owner C/O NEW ENTERPRISE ASSOCIATES, 1954 GREENSPRING DRIVE, SUITE 600, TIMONIUM MD 21093
Nea 18 Venture Growth Equity, L.p. 10 percent owner 1954 GREENSPRING DRIVE, SUITE 600, TIMONIUM MD 21093
Nea 17 Gp, Llc 10 percent owner 1954 GREENSPRING DRIVE, SUITE 600, TIMONIUM MD 21093
Nea Partners 17, L.p. 10 percent owner 1954 GREENSPRING DRIVE, SUITE 600, TIMONIUM MD 21093
New Enterprise Associates 17, L.p. 10 percent owner 1954 GREENSPRING DRIVE, SUITE 600, TIMONIUM MD 21093
Michael A Carson officer: CEO, Bright HealthCare C/O BRIGHT HEALTH GROUP INC., 8000 NORMAN CENTER DRIVE SUITE 1200, MINNEAPOLIS MN 55437